Loading…
Mandate Oil Spill Investigations and Emergency Rules (MOSIER) Act of 2016
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Mandate Oil Spill Investigations and Emergency Rules (MOSIER) Act of 2016 This bill reauthorizes through FY2020 the National Transportation Safety Board (NTSB). A specified amount is set-aside for costs to carry out railroad accident investigations and investigations of significant railroad incidents. The bill requires the NTSB to investigate derailments involving a significant release of hazardous materials into the environment within close proximity to communities, personal property, or critical landscapes. The bill expands the authority of the Department of Transportation (DOT) to issue emergency orders for unsafe occurrences causing, or potentially causing, an emergency or reoccurring situation involving a hazard of death, personal injury, or significant harm to the environment. DOT shall establish and enforce a national standard for the maximum volatility of crude oil to be permitted to be shipped by rail based on the safest practicable standard.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2016 · third_quarter · Railroads
HR 1043/S 546 Response Act of 2015 (monitor) HR 1679 Bakken Crude Stabilization Act of 2015 (monitor) S 797 Railroad Infrastructure Financing Improvement Act (monitor) S 853 Rail Shipper Fairness Act of 2015 (oppose) S 1175 Hazardous Materials Rail Transportation Safety Improvement Act of 2015 (oppose) HR 1405 Rails Act (monitor) S 1634 Railroad Antitrust Enforcement Act of 2015 (oppose) S 1626 Railroad Reform, Enhancement, and Efficiency Act (monitor) HR 1763 - Two PersonCrew (opposed) HR 354 - To impose a civil penalty against a railroad carrier when a shift change of train employees causes a blockage of vehicular traffic at a grade crossing (oppose) HR 5616 Tulare Youth Recreation and Womens History Enhancement Act (support) HR 5786 - Community Protection & Preparedness Act (oppose) HR 5762 - Hazardous Materials Rail Transportation Safety Improvement Act (oppose) S.3187 - Mandate Oil Spill Investigations & Emergency Rules Act (monitor) Various issues dealing w/ the transportation of oil by rail Various efforts to clarify 1875 Right of Way definition Various issues associated with rulemakings at the Surface Transportation Board
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,448,123 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Railroads
HR 1043/S 546 Response Act of 2015 (monitor) HR 1679 Bakken Crude Stabilization Act of 2015 (monitor) S 797 Railroad Infrastructure Financing Improvement Act (monitor) S 853 Rail Shipper Fairness Act of 2015 (oppose) S 1175 Hazardous Materials Rail Transportation Safety Improvement Act of 2015 (oppose) HR 1405 Rails Act (monitor) S 1634 Railroad Antitrust Enforcement Act of 2015 (oppose) S 1626 Railroad Reform, Enhancement, and Efficiency Act (monitor) HR 1763 - Two PersonCrew (opposed) HR 354 - To impose a civil penalty against a railroad carrier when a shift change of train employees causes a blockage of vehicular traffic at a grade crossing (oppose) HR 5616 Tulare Youth Recreation and Womens History Enhancement Act (support) HR 5786 - Community Protection & Preparedness Act (oppose) HR 5762 - Hazardous Materials Rail Transportation Safety Improvement Act (oppose) S.3187 - Mandate Oil Spill Investigations & Emergency Rules Act (monitor) Various issues dealing w/ the transportation of oil by rail Various efforts to clarify 1875 Right of Way definition Various issues associated with rulemakings at the Surface Transportation Board
Client expense: $1,127,912 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Railroads
HR 1043/S 546 Response Act of 2015 (monitor) HR 1679 Bakken Crude Stabilization Act of 2015 (monitor) S 797 Railroad Infrastructure Financing Improvement Act (monitor) S 853 Rail Shipper Fairness Act of 2015 (oppose) S 1175 Hazardous Materials Rail Transportation Safety Improvement Act of 2015 (oppose) HR 1405 Rails Act (monitor) S 1634 Railroad Antitrust Enforcement Act of 2015 (oppose) S 1626 Railroad Reform, Enhancement, and Efficiency Act (monitor) HR 1763 - Two PersonCrew (opposed) HR 354 - To impose a civil penalty against a railroad carrier when a shift change of train employees causes a blockage of vehicular traffic at a grade crossing (oppose) HR 5616 Tulare Youth Recreation and Womens History Enhancement Act (support) HR 5786 - Community Protection & Preparedness Act (oppose) HR 5762 - Hazardous Materials Rail Transportation Safety Improvement Act (oppose) S.3187 - Mandate Oil Spill Investigations & Emergency Rules Act (monitor) Various issues dealing w/ the transportation of oil by rail Various efforts to clarify 1875 Right of Way definition Various issues associated with rulemakings at the Surface Transportation Board
Client expense: $1,448,123 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Telecommunications
Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act.
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Telecommunications
Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Telecommunications
Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Health Issues
Issues related to the implementation of medical gas provisions of S.3187 Prescription Drug User Fee Act (PDUFA), (P.L. 112-144).
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Telecommunications
Medical device tax; IC-DISC; implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; FY 2016 budget; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Health Issues
Issues related to the implementation of medical gas provisions of S.3187 Prescription Drug User Fee Act (PDUFA), (P.L. 112-144).
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Taxation/Internal Revenue Code
Medical device tax; IC-DISC; implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; FY 2016 budget; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; community health centers and school health; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 160/S. 149); accountable care organizations; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act; FY 2016 budget; Sunshine Act/Open Payment implementation; 21st Century Cures Act (H.R. 6); The Medicare Access and CHIP Reauthorization Act (H.R. 2); Medicare Telehealth Parity Act (H.R. 2948)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Taxation/Internal Revenue Code
Medical device tax; IC-DISC; implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; FY 2016 budget; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; community health centers and school health; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 160/S. 149); accountable care organizations; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act; FY 2016 budget; Sunshine Act/Open Payment implementation; 21st Century Cures Act (H.R. 6); The Medicare Access and CHIP Reauthorization Act (H.R. 2)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Manufacturing
HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period H.R. 6, 21st Century CURES Act - discussed addition of small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Health Issues
HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period H.R. 6, 21st Century CURES Act - discussed addition of small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Medical/Disease Research/Clinical Labs
HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period H.R. 6, 21st Century CURES Act - discussed addition of small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; community health centers and school health; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 160/S. 149); accountable care organizations; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act; SGR reform; FY 2016 budget; Sunshine Act/Open Payment implementation; H.R. 2; 21st Century Cures
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Taxation/Internal Revenue Code
Medical device tax; IC-DISC; implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); H.R. 160/S. 149; FY 2016 budget; implementation of S. 3187, the Food and Drug Administration Safety and Innovation Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Health Issues
HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Manufacturing
HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Medical/Disease Research/Clinical Labs
HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE